Pharmaceuticals

Global Medical Device Clinical Trials Market Report 2026–2035: Key Forecasts and Growth Areas

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the medical device clinical trials market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Medical Device Clinical Trials Market from 2026 to 2030?

The medical device clinical trials market size has experienced significant expansion in recent years. It is anticipated to grow from $18.07 billion in 2025 to $19.36 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. This market’s past growth can be attributed to increased medical device innovation, rigorous regulatory approval requirements, a heightened demand for patient safety validation, the broadening of hospital-based clinical research, and a rise in investment toward generating clinical evidence.

The medical device clinical trials market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast timeframe is attributable to several factors, including the proliferation of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the enlargement of digital trial platforms, the growing integration of remote patient monitoring into trials, and the increasing worldwide scope of clinical investigations. Key developments anticipated during this period encompass the greater embrace of decentralized clinical trials, the expanding utilization of real-world evidence in device studies, a heightened emphasis on post-approval and extended safety research, the broadening of adaptive and hybrid trial methodologies, and a surging requirement for trial management that adheres to regulatory standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Drivers Are Affecting Demand In The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to drive expansion within the medical device clinical trials market in the future. These are enduring health conditions characterized by gradual progression and a continuous need for medical care. The rise in chronic diseases stems from inactive lifestyles, where extended periods of sitting at desks or using electronic devices decrease calorie burning and impair cardiovascular health, resulting in conditions like obesity, diabetes, and hypertension. This escalation in chronic diseases necessitates medical device clinical trials to create and confirm the efficacy of novel devices for accurate diagnosis, treatment, and ongoing management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion people globally were affected by diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is propelling the expansion of the medical device clinical trials market.

Which Segments Are Gaining Traction In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Industry Trends Are Transforming The Medical Device Clinical Trials Market?

Leading companies active in the medical device clinical trials market are directing their efforts toward developing AI-powered medical device software. Their goal is to refine clinical trial protocols and improve resource allocation, thereby enhancing trial efficiency and reducing overall costs. AI-powered medical device software refers to applications in healthcare that leverage artificial intelligence (AI) algorithms, specifically machine learning or deep learning, to support or automate various medical tasks. For example, in January 2025, Risklick, a pharmaceutical company based in Switzerland, unveiled Protocol AI. This AI-based software is specifically designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in just minutes. This innovation significantly cuts down the time and expense typically associated with protocol development, a process that traditionally takes around six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Who Are The Primary Competitors In The Global Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Medical Device Clinical Trials Market?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Medical Device Clinical Trials Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795